Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,935.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,935.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

Fri, 08th Apr 2016 07:37

LONDON (Alliance News) - Shares in London were higher Friday morning, with resource stocks leading the gainers as the oil prices take back some of their Thursday losses.

The FTSE 100 was up 0.8%, or 50.59 points, at 6,187.48. In Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were up 0.6% and 0.5%, respectively.

"Oil prices continue to get excited by the April 17 Doha meeting despite a chance of a production freeze deal looking slim to say the least with Iran saying 'No' and Saudi Arabia saying 'Only with Iran'. Desire is there, but as in break-up speak 'it's complicated'," said Accendo Markets head of research Mike van Dulken.

Brent oil was at USD40.11 a barrel shortly after the London equities open, higher than the USD38.93 a barrel at the close on Thursday.

Investors will keep a close eye later Friday on the US Baker Hughes oil rig count, scheduled for after the London equities close at 1800 BST.

Resource stocks were among the best performers in the FTSE 100, with Anglo American up 2.7%, Glencore up 2.4%, Rio Tinto up 2.3% and BHP Billiton up 2.2%. Oil company BP was up 1.3%, while Royal Dutch Shell's 'A' shares were up 1.1%.

Also among risers was Vodafone Group, after Deutsche Bank added the telecommunications company to its Short Term Buy List, according to traders.

Banks were also brightly green, with Standard Chartered up 2.1%, Royal Bank of Scotland Group up 1.6% and Lloyds Banking Group up 1.2%.

European banking stocks were hit Thursday after the ECB minutes "appeared to leave the door open to further negative interest rates, despite fears from some members about the adverse impacts on bank profitability," said CMC Markets analyst Jasper Lawler.

In its meeting on March 10, the ECB cut the main refinancing rate, which the central bank uses to boost liquidity, by five basis points to a record low 0.0%. The already-negative deposit rate was cut by 10 basis points to -0.40%, while there was a surprise five-basis-point cut to its marginal lending facility rate to 0.25%.

In the accounts, the ECB policymakers said they decided that a limited cut was appropriate as prospect of further cut cannot be ruled out if the inflation outlook deteriorates. Governing Council members broadly supported a further cut in the deposit facility rate and stressed the importance of communication and the link to the formulation of forward guidance.

The euro was at USD1.1354 after the open Friday. The single currency hit a high of USD1.1453 on Thursday but retreated following the release of the ECB accounts, standing at USD1.1373 at the London equities close.

Information services company Experian was the worst blue-chip performer early Friday, down 1.0%, after being downgraded to Reduce from Buy by HSBC. Meanwhile, insurer Schroders was cut to Neutral from Outperform by Exane BNP, sending its shares down 0.2%.

The FTSE 250 was up 0.4% at 16,781.27, while the AIM All-Share was up 0.1% at 717.83.

Hikma Pharmaceuticals and Vectura Group said the new drug application for their fluticasone propionate and salmeterol inhalation powder has been accepted for filing by the Food & Drug Administration in the US.

The two pharmaceutical companies are working together on the inhalation powder, which is a generic version of GlaxoSmithKline's Advair Diskus, which is used to treat asthma and to maintain treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Shares in Hikma were up 1.0%, while Vectura Group was the best mid-cap performer, up 5.0%. In the FTSE 100, GlaxoSmithKline shares were down 0.1%.

At the other end of the FTSE 250, DFS Furniture was down 5.3% at 303.20 pence. Private equity firm Advent International said it agreed to sell a 14.1% stake in the sofa retailer for GBP90.0 million. Advent agreed to sell 30.0 million shares at 300.00 pence per share to institutional investors, leaving the private equity firm with a 24.1% stake in DFS, held through 51.4 million shares. Shares in DFS closed at 320.90p on Thursday.

UK manufacturing and industrial production data and trade balance are due at 0930 BST, while UK's NIESR gross domestic product estimate is due at 1500 BST.

"The CBI Industrial Trends survey and the manufacturing Purchasing Manager's Index output index both send the signal of some fall in manufacturing output in February," said analysts at French bank Societe Generale. "Accordingly, we predict that manufacturing production fell by 0.3% month-on-month in February after a rise by 0.7% month-on-month in January. Meanwhile, the trade deficit should stay within its narrow range, widening slightly from GBP3459 million to GBP3700 million in February".

In Asia on Friday, the Japanese Nikkei 225 index closed up 0.5%. In China, the Shanghai Composite ended down 0.8%, while the Hang Seng index in Hong Kong is down 0.2%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.